IV Dosing, BSA-Based

Uses body surface area to calculate an individualized intravenous drug dose.

g/sq.mmg/sq.mmcg/sq.m
g/mLmg/mLmcg/mL
sq.m

适用指征

Use for IV cytotoxic chemotherapy and selected agents where exposure correlates with body size, providing a practical surrogate for drug clearance. Clinically useful for full weight‑based dosing in obese adults to avoid underdosing (ASCO guideline 1 [Level I evidence]). Offers standardized starting doses when pharmacokinetic data are limited, though BSA poorly reduces interpatient PK variability for most drugs (JNCI PK analysis, 1650 pts 2 [Level II evidence]).

洞见与注意事项

Use full actual‑weight BSA for adults; any standard formula is acceptable, as no method improves accuracy 1 [Level I evidence].

  • Avoid dose capping unless mandated; underdosing worsens outcomes in obese patients.
  • Extremes of size: BSA does not reliably predict clearance and may misdose drugs with narrow therapeutic windows.
  • Children <6 y: avoid BSA—use mg/kg to reduce toxicity 2 [Level III evidence].
  • Consider PK‑guided strategies when available.